María Gabriela Otero

María Gabriela Otero

Auto-generated profile, based on publicly available information

María Gabriela Otero

Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2019 in American Journal of Medical Genetics Part C: Seminars in Medical Genetics
Verified
Journal Article
Closed access
PDF file
TPTyler Mark Pierson
Tyler Mark Pierson
MOMaria G. Otero
Maria G. Otero
KGKatheryn Grand
Katheryn Grand
ACAndrew Choi
Andrew Choi
JGJohn M. Graham
John M. Graham
JMJoel P. Mackay
Joel P. Mackay

15 April 2020 in Development
Verified
Journal Article
Open access
PDF file
TSTrinidad M. M. Saez
Trinidad M. M. Saez
IFIvan Fernandez
Ivan Fernandez
MRMaría S. Rodriguez
María S. Rodriguez
MAMatías Alloatti
Matías Alloatti
MOMaría G. Otero
María G. Otero
TFTomás L. Falzone
Tomás L. Falzone
Endocannabinoids (eCB) modulate growth cone dynamics and axonal pathfinding through the stimulation of cannabinoid type-1 receptors (CB1R), the function of which depends on their delivery and precise presentation at the growth cone surface. However, the mechanism involved in the axonal transport of CB1R and its transport role in eCB signaling remains elusive. As mutations in the kinesin-1 molecular motor have been identified in patients with abnormal cortical development and impaired white matter integrity, we studied the defects in axonal pathfinding and fasciculation in mice lacking the kinesin light chain 1 (Klc1−/−) subunit of kinesin-1. Reduced levels of CB1R were found in corticofugal projections and axonal growth cones in Klc1−/− mice. By live-cell imaging of CB1R-eGFP we characterized the axonal transport of CB1R vesicles and described the defects in transport that arise after KLC1 deletion. Cofilin activation, which is necessary for actin dynamics during growth cone remodeling, is impaired in the Klc1−/− cerebral cortex. In addition, Klc1−/− neurons showed expanded growth cones that were unresponsive to CB1R-induced axonal elongation. Together, our data reveal the relevance of kinesin-1 in CB1R axonal transport and in eCB signaling during brain wiring.

1 June 2018 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
MOMaría Gabriela Otero
María Gabriela Otero
IFIvan Fernandez
Ivan Fernandez
AHAlan Earle Hallberg
Alan Earle Hallberg
LCLucas Eneas Cromberg
Lucas Eneas Cromberg
MRMaría Cecilia De Rossi
María Cecilia De Rossi
TFTomás Luis Falzone
Tomás Luis Falzone
Alzheimer disease (AD) pathology includes the accumulation of poly-ubiquitylated (also known as poly-ubiquitinated) proteins and failures in proteasome-dependent degradation. Whereas the distribution of proteasomes and its role in synaptic function have been studied, whether proteasome activity regulates the axonal transport and metabolism of the amyloid precursor protein (APP), remains elusive. By using live imaging in primary hippocampal neurons, we showed that proteasome inhibition rapidly and severely impairs the axonal transport of APP. Fluorescence cross-correlation analyses and membrane internalization blockage experiments showed that plasma membrane APP does not contribute to transport defects. Moreover, by western blotting and double-color APP imaging, we demonstrated that proteasome inhibition precludes APP axonal transport by enhancing its endo-lysosomal delivery, where β-cleavage is induced. Taken together, we found that proteasomes control the distal transport of APP and can re-distribute Golgi-derived vesicles to the endo-lysosomal pathway. This crosstalk between proteasomes and lysosomes regulates the intracellular APP dynamics, and defects in proteasome activity can be considered a contributing factor that leads to abnormal APP metabolism in AD. This article has an associated First Person interview with the first author of the paper.

Verified
Journal Article
Open access
PDF file
MOMaria G. Otero
Maria G. Otero
SBShaughn Bell
Shaughn Bell
ALAlexander H. Laperle
Alexander H. Laperle
GLGeorge Lawless
George Lawless
ZMZachary Myers
Zachary Myers
CSClive N Svendsen
Clive N Svendsen
While cells in the human body function in an environment where the blood supply constantly delivers nutrients and removes waste, cells in conventional tissue culture well platforms are grown with a static pool of media above them and often lack maturity, limiting their utility to study cell biology in health and disease. In contrast, organ-chip microfluidic systems allow the growth of cells under constant flow, more akin to the in vivo situation. Here, we differentiated human induced pluripotent stem cells into dopamine neurons and assessed cellular properties in conventional multi-well cultures and organ-chips. We show that organ-chip cultures, compared to multi-well cultures, provide an overall greater proportion and homogeneity of dopaminergic neurons as well as increased levels of maturation markers. These organ-chips are an ideal platform to study mature dopamine neurons to better understand their biology in health and ultimately in neurological disorders.